immune – media

Is Grey Hair Linked to Our Immune Systems?

A research study from the scientists at the National Institutes of Health and the University of Alabama, Birmingham (UAB) discovered that there was a connection between the genes that code for hair color and the genes that signal infection in the body. This study had revealed a reason as to why some people’s hair turn grey in response to an illness.
- Source: Ddu
- 462
- May 22, 2018
immune Researches
Third Rock debuts immunometabolism startup Rheos with $60M launch round

Global pharmaceutical company Mylan N.V. (MYL) today announced that it will introduce in the U.S. a third cost-saving HIV combination. The U.S. Food and Drug Administration (FDA) approved Symfi™ (efavirenz, lamivudine and tenofovir disoproxil fumarate) 600 mg/300 mg/300 mg tablets, a once-daily, single-tablet regimen (STR), indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 40 kg.
- Source: pharmacompass
- 645
- March 30, 2018
financing immune Market Views
Aspyrian Therapeutics Inc. announces successful advances in RM-1929 clinical development

Aspyrian Therapeutics Inc. announces successful advances in RM-1929 clinical development in recurrent Head and Neck Cancer, including Fast Track designation granted by the FDA, initiation of clinical studies in Japan, and plans to start pivotal studies, which will incorporate the evaluation of anti-cancer immune responses, in early 2018.
- Source: Prnewswire
- 757
- January 19, 2018
anti-cancer immune New Approvals RM-1929
Baby born with bubble boy disease has no immune system and must live in total isolation

A 10-month-old boy born without an immune system has been confined to his sanitized home his entire life and only leaves for doctor's visits. Sebastian Romero was diagnosed with severe combined immunodeficiency (SCID) at two weeks old, a rare genetic disorder known as 'bubble boy' disease that left him with no infection-fighting cells.
- Source: dailymail
- 567
- December 28, 2017
bubble boy immune Researches SCID
Blood test offers new way to monitor disease activity

Monitoring disease activity in individuals with multiple sclerosis, either to predict flare-ups or to check treatment response, might be done with a simple blood test that measures levels of a nerve protein, according to a new study from Norway.
- Source: medicalnewstoday
- 628
- December 1, 2017
immune Market Views multiple sclerosis nerves
Two years in, the team at NousCom bags $49M to fund first human studies of neoantigen drugs

As NousCom CEO Alfredo Nicosia likes to say, the Basel-based biotech is a relative fledgling at 2-years of age. But the core research team there has been working together for quite a few years.
- Source: Endpts
- 592
- November 9, 2017
immune Market Views oncology vaccine
KU Leuven researchers identify new rapid response mechanism against bacterial infections

When bacteria enter our body, they kick-start a powerful immune response. But this chain of reactions doesn't fully account for our immediate responses. Researchers at KU Leuven, Belgium, show that so-called ion channels play a key role as 'first responders'.
- Source: news-medical
- 610
- October 24, 2017
bacteria immune infections
Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines

Eli Lilly and Company (LLY) and CureVac AG have announced a global immuno-oncology collaboration focused on the development and commercialization of up to five potential cancer vaccine products based on CureVac's proprietary RNActive® technology. The companies will use messenger RNA (mRNA) technology that targets tumor neoantigens for a more robust anti-cancer immune response.
- Source: Finance
- 667
- October 20, 2017
immune Market Views mRNA vaccine
Cancer Startup Torque Therapeutics Nabs $21 Million and Sets Up Shop in Kendall Square

Torque Therapeutics has come out of stealth mode to launch with a $21 million Series A financing. It is looking to raise another $14 million, according to its filing with the U.S. Securities and Exchange Commission (SEC).
- Source: Biospace
- 846
- September 15, 2017
cell immune Series therapy
FDA clears BD’s immunological IVD system for commercialization

FDA has granted 510(k) clearance to Becton, Dickinson and Company’s (BD) in-vitro diagnostic (IVD) device, FACSLyric flow cytometer system.
- Source: Medicaldevice-network.com
- 533
- July 27, 2017
Clinical FDA immune New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.